본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

코의 Angiocentric Immunoproliferative Lesions(AILs)

이용수 0

영문명
Angiocentric Immunoproliferative Lesions(AILs) in Nose
발행기관
대한두경부종양학회
저자명
한지연(Ji Youn Han) 김재유(Jae You Kim) 이연수(Youn Soo Lee) 정수미(Su Mee Chung) 김민식(Min Shik Kim) 윤세철(Sei Chul Yoon) 김훈교(Hoon Kyo Kim) 조승호(Seung Ho Cho) 김병기(Byung Kee Kim) 경식(Kyung Shik Lee) 김동집(Dong Jip Kim)
간행물 정보
『대한두경부종양학회지』제12권 제1호, 16~21쪽, 전체 6쪽
주제분류
의약학 > 종양학
파일형태
PDF
발행일자
1996.06.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Lymphomatoid granulomatosis, polymorphic reticulosis, midline malignant reticulosis, or lethal midline granuloma have similar histologic features of an angiocentric and angiodestructive lymphoreticular proliferation representing the same nosologic entity. The term 'angiocentric immunoproliferative lesion' (AIL) was proposed by Jaffe, Costa, and Martin. The malignant potential of AILs is originally uncertain, but the facts that AILs have a relatively short survival, and most of them usually progress to an overt malignant lymphoma and survival is inversely proportional to the large, atypical lymphoreticular cells suggest that AILs are malignane. We experienced 17 AILs in nose during 16-year period and retrogradely analized them to recognize the problems in the diagnosis and to establish the further therapeutic strategies. The results were as follows; Twelve of total 17 patients who had diagnosed as histologic grade 1 and 2 had received radiation therapy as an initial treatment and the complete response rate was 91.7%(11/12), but 6 out of 11 had local recurrence and 5 had progress to overt maligant lymphoma within 2years. Three patients with the histologic grade 3 and 2 with unclear histologic grade had received CHOP chemotherapy and there was 1 case with complete response. Two patients with unclear histologic grade had been proved to be malignant histiocytosis by bone marrow biopsy during the clinical course. The overall duration of survival was 2 - 119 months and the 5-year survival rate was 71.9%. And the achievement of initial complete response was the most important prognostic factor of overall survival(P=0.006). Our results suggest that the treatment strategy according to the histologic grading scheme is efficient and more aggressive combination chemotherapy may be necessary to achieve complete response in patients with histologic grade III and II, because most of them progress to overt malignant lymphoma during its process.

목차

Abstract
서론
대상 및 방법
통계처리
결과
고찰
결론
References

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

한지연(Ji Youn Han),김재유(Jae You Kim),이연수(Youn Soo Lee),정수미(Su Mee Chung),김민식(Min Shik Kim),윤세철(Sei Chul Yoon),김훈교(Hoon Kyo Kim),조승호(Seung Ho Cho),김병기(Byung Kee Kim),경식(Kyung Shik Lee),김동집(Dong Jip Kim). (1996).코의 Angiocentric Immunoproliferative Lesions(AILs). 대한두경부종양학회지, 12 (1), 16-21

MLA

한지연(Ji Youn Han),김재유(Jae You Kim),이연수(Youn Soo Lee),정수미(Su Mee Chung),김민식(Min Shik Kim),윤세철(Sei Chul Yoon),김훈교(Hoon Kyo Kim),조승호(Seung Ho Cho),김병기(Byung Kee Kim),경식(Kyung Shik Lee),김동집(Dong Jip Kim). "코의 Angiocentric Immunoproliferative Lesions(AILs)." 대한두경부종양학회지, 12.1(1996): 16-21

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제